On Friday, A World Health Organization (WHO) panel recommended the use of Regeneron (REGN.O) and Roche's (ROG.S) COVID-19 antibody cocktail for patients at high risk of hospitalizations and those severely ill with no natural antibodies. The treatment has been granted U.S. emergency authorization which gained attention when it was used to